相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
Zhongxing Liang et al.
BIOCHEMICAL PHARMACOLOGY (2010)
The miR-17-92 Cluster of MicroRNAs Confers Tumorigenicity by Inhibiting Oncogene-Induced Senescence
Lixin Hong et al.
CANCER RESEARCH (2010)
Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status
Xuan Zhou et al.
LABORATORY INVESTIGATION (2010)
Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection
Robert E. Lanford et al.
SCIENCE (2010)
miR-21 as a key regulator of oncogenic processes
S. Duygu Selcuklu et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
MicroRNA Silencing in Primates: Towards Development of Novel Therapeutics
Andreas Petri et al.
CANCER RESEARCH (2009)
miR-19 is a key oncogenic component of mir-17-92
Virginie Olive et al.
GENES & DEVELOPMENT (2009)
MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells
Yu-Zhuo Pan et al.
MOLECULAR PHARMACOLOGY (2009)
Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells
Hua Zhu et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NFκB pathway
Byeong Hyeok Choi et al.
CANCER LETTERS (2008)
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Shuomin Zhu et al.
CELL RESEARCH (2008)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
Olga Kovalchuk et al.
MOLECULAR CANCER THERAPEUTICS (2008)
LNA-mediated microRNA silencing in non-human primates
Joacim Elmen et al.
NATURE (2008)
CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway
Zhongxing Liang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
miR-21-mediated tumor growth
M.-L. Si et al.
ONCOGENE (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
LNA-modified oligonucleotides mediate specific inhibition of microRNA function
Ulf Andersson Orom et al.
GENE (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Improved targeting of miRNA with antisense oligonucleotides
Scott Davis et al.
NUCLEIC ACIDS RESEARCH (2006)
AKT phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer
E Oki et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Regulation of the cell surface expression of human BCRP/ABCG2 by the phosphorylation state of Akt in polarized cells
T Takada et al.
DRUG METABOLISM AND DISPOSITION (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: The Austrian breast and colorectal cancer study group
M Filipits et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
Real-time expression profiling of microRNA precursors in human cancer cell lines
JM Jiang et al.
NUCLEIC ACIDS RESEARCH (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Phosphatidylinositol 3′-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells
JT Lee et al.
CANCER RESEARCH (2004)
Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4
ZX Liang et al.
CANCER RESEARCH (2004)
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
LA Doyle et al.
ONCOGENE (2003)
PTEN controls immunoreceptor (immunoreceptor tyrosine-based activation motif) signaling and the activation of Rac
JS Kim et al.
BLOOD (2002)
Multidrug resistance in cancer: Role of ATP-dependent transporters
MM Gottesman et al.
NATURE REVIEWS CANCER (2002)
microRNAs: Tiny regulators with great potential
V Ambros
CELL (2001)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
